Imagine nearly 4 in 10 women feeling dismissed, misunderstood, and left to navigate a critical life transition alone. This is the stark reality revealed by a groundbreaking national survey on perimenopause, a stage of life shrouded in silence and often misunderstood. The 2025 “Perimenopause Focus” survey, conducted by Biote, a leader in hormone replacement therapy and healthy aging solutions, exposes a healthcare system failing women at a pivotal moment. But here's where it gets even more concerning: these women aren't just being overlooked; they're being misdiagnosed, with potentially devastating consequences.
The survey, which gathered insights from over 1,000 U.S. women aged 30 to 60, paints a troubling picture. Nearly 40% of respondents felt they were misdiagnosed when seeking help for perimenopause symptoms, often being treated for depression, anxiety, or mood swings without addressing the underlying hormonal imbalance. And this is the part most people miss: these misdiagnoses aren’t just inconvenient—they’re undermining women’s health and well-being.
Dr. Bruce Dorr, Senior Medical Advisor at Biote, highlights a critical issue: “We’re treating symptoms in isolation instead of addressing the root cause—hormonal imbalance. Many women sense something is wrong with their diagnosis but don’t know where to turn for better care.” This gap in understanding and treatment leaves women feeling frustrated and unsupported.
The conversation (or lack thereof) with healthcare providers is equally alarming. Less than half of the women surveyed reported their doctors initiating discussions about perimenopause during regular appointments. Even more troubling, nearly 1 in 5 women felt their concerns were dismissed or not fully addressed. With only 31% of OB/GYN residency programs incorporating menopause training, it’s no wonder providers often feel ill-equipped to support women through this stage.
This systemic failure forces women to take matters into their own hands. Instead of relying on medical professionals, 42% turn to Google and 42% to family members for information, while only 26% seek guidance from their doctors. This knowledge gap leaves women unprepared for the physical and mental challenges of perimenopause. For instance:
- 56% wished they’d known symptoms can start earlier than expected.
- 41% wished they’d known treatment options exist for perimenopause and its symptoms.
- 37% wished they’d known symptoms can be severe and disruptive.
- 35% wished they’d known perimenopause impacts mental health as much as physical health.
- 25% wished they’d known how to advocate for themselves with doctors.
But here’s where it gets controversial: The FDA’s recent decision to remove the black box warning from hormone therapies coincides strikingly with this survey’s findings. Dr. Dorr emphasizes, “This regulatory change is a game-changer. The outdated warnings scared away both patients and providers, preventing women from accessing treatments that could address their hormonal issues.” Is this a turning point for women’s healthcare, or will systemic barriers continue to hinder progress?
The survey also raises a thought-provoking question: Why is the burden of finding specialized care placed on women, rather than ensuring all healthcare providers are adequately trained? While legislative efforts aim to improve clinical education, millions of women can’t afford to wait for systemic change—they need comprehensive care now.
What do you think? Is the healthcare system failing women during perimenopause? Should more be done to educate providers and destigmatize hormone therapies? Share your thoughts in the comments—let’s spark a conversation that could drive real change.
For those eager to dive deeper, the full study is available at Biote’s Learning Center. Let’s not just talk about it—let’s demand better for women’s health.
